We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.11B
AUM Growth
+$508M
Cap. Flow
+$71.5M
Cap. Flow %
1.4%
Top 10 Hldgs %
29.75%
Holding
158
New
25
Increased
53
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$46M
2
ANNX icon
Annexon
ANNX
+$41.6M
3
CTAS icon
Cintas
CTAS
+$41M
4
GTM
ZoomInfo Technologies
GTM
+$40.9M
5
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$39.2M

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$53.4M
2
LII icon
Lennox International
LII
+$42.7M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$40.3M
4
SPLK
Splunk Inc
SPLK
+$39.6M
5
ZGNX
Zogenix, Inc.
ZGNX
+$32.7M

Sector Composition

Rank Sector Weight
1 Healthcare 40.89%
2 Technology 24.02%
3 Industrials 10.32%
4 Consumer Discretionary 8.24%
5 Communication Services 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STSA
151
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-983,382
Closed -$28.3M
AIMT
152
DELISTED
Aimmune Therapeutics
AIMT
– –
-3,193,117
Closed -$53.4M
MNTA
153
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-1,212,000
Closed -$40.3M
ARYAW
154
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
– –
-400,000
Closed -$2.14M
TCF
155
DELISTED
TCF Financial Corporation Common Stock
TCF
– –
-93,200
Closed -$2.74M
ZGNX
156
DELISTED
Zogenix, Inc.
ZGNX
– –
-1,211,300
Closed -$32.7M
3 4 5 6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Eventide Asset Management held 158 positions worth $5.11B, up 11% from $4.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management's Q3 2020 filing shows 25 new, 53 increased, 18 reduced and 16 closed positions. Its largest new stake was Ecolab: 230,000 shares worth $46M. The largest sale was Aimmune Therapeutics, an estimated $53.4M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2020 buy was Ecolab: 230,000 shares worth $46M.
  • Eventide Asset Management added most to Dynatrace in Q3 2020, an estimated $32.6M increase.
  • Eventide Asset Management's biggest Q3 2020 reduction was Lennox International, cutting an estimated $42.7M.
  • Eventide Asset Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $53.4M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $5.11B portfolio in Q3 2020.
  • Eventide Asset Management opened 25 new positions and closed 16 in Q3 2020.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $5.11B.

Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.